Introduction Clinicians and researchers have traditionally relied on treatment retention and
opioid abstinence as the primary measures of treatment success for people with opioid use …

Background and Objectives Medications for opioid use disorder (MOUD) reduce opioid use
and overdose; however, MOUD clinical trials have used varying primary outcomes to …

Objective: Opioid use disorder (OUD) affects approximately 5.6 million people in the United
States annually, yet rates of the use of effective medication for OUD (MOUD) treatment are …

Introduction: This study explored factors influencing patient access to medications for opioid
use disorder (OUD), particularly for individuals eligible but historically suboptimal follow-up …

Background Hospitalizations related to opioid use disorder (OUD) are rising. Addiction
consultation services (ACS) increasingly provide OUD treatment to hospitalized patients, but …

Background Addiction health service researchers have focused efforts on opioid use
disorder (OUD) and strategies to address the emerging public health threats associated with …

Background Opioid use disorder (OUD), a chronic disease, is a major public health problem.
Despite availability of effective treatment, too few people receive it and treatment retention is …

Background In the US, emergency room visits and overdoses related to prescription opioids
have soared and the rates of illicit opioid use, including heroin and fentanyl, are increasing …

Background Maintenance treatments with medications for opioid use disorder (MOUD) are
highly effective at reducing overdose risk while patients remain in care. However, few …

Objective Utilization of medications for opioid use disorder (MOUD) has not been widely
adopted by primary care providers. This study sought to identify interprofessional barriers …